Claudia Turetschek is a seasoned professional in the pharmaceutical industry, currently serving as a Senior Project Advisor and Senior Program Manager at AOP Health since March 2013. Turetschek has extensive experience with the BESREMi® program, overseeing EU-wide market access, product introduction, and clinical study management. Previous roles include Program Coordinator and CMC Lead, where Turetschek managed CMC activities for late Phase III drug/device combination products and represented the Pharmaceutical Development function at R&D Project Management Core Teams. Earlier experience includes project management positions at Baxter Innovations GmbH, where Turetschek contributed to drug development programs leading to multiple FDA approvals, and as a Junior Scientist at the Mbeya Medical Research Programme, focusing on tuberculosis diagnostics. Turetschek holds two Master of Science degrees in Drug Regulatory Affairs and Medical & Pharmaceutical Biotechnology from the University of Applied Sciences in Krems, Austria.